Showing results (401-410 of 430) with videos related to

Sort By:
Pageof 43
Oncotarget|November 12, 2015
Expression of androgen receptor splice variants in clinical breast cancersTheresa E Hickey, Connie M Irvine, Heidi Dvinge, et al.
The Journal of Clinical Investigation|April 29, 2020
The landscape of RNA polymerase II-associated chromatin interactions in prostate cancerSusmita G Ramanand, Yong Chen, Jiapei Yuan, et al.
Molecular Oncology|August 18, 2018
A patient-derived explant (PDE) model of hormone-dependent cancerMargaret M Centenera, Theresa E Hickey, Shalini Jindal, et al.
Science Translational Medicine|June 8, 2012
A validated tumorgraft model reveals activity of dovitinib against renal cell carcinomaSharanya Sivanand, Samuel Peña-Llopis, Hong Zhao, et al.
Cell Reports|January 19, 2018
BRD4 Promotes DNA Repair and Mediates the Formation of TMPRSS2-ERG Gene Rearrangements in Prostate CancerXiangyi Li, GuemHee Baek, Susmita G Ramanand, et al.
Cancer Discovery|September 21, 2012
Dual roles of PARP-1 promote cancer growth and progressionMatthew J Schiewer, Jonathan F Goodwin, Sumin Han, et al.
JCI Insight|July 26, 2022
Targeting ESR1 mutation-induced transcriptional addiction in breast cancer with BET inhibitionSm N Udden, Qian Wang, Sunil Kumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2018
Targeting Bromodomain and Extra-Terminal (BET) Family Proteins in Castration-Resistant Prostate Cancer (CRPC)Jonathan Welti, Adam Sharp, Wei Yuan, et al.
Communications Biology|October 30, 2021
LIFR inhibition enhances the therapeutic efficacy of HDAC inhibitors in triple negative breast cancerMengxing Li, Suryavathi Viswanadhapalli, Bindu Santhamma, et al.
Cancer Research|July 30, 2017
Androgen Receptor Variants Mediate DNA Repair after Prostate Cancer IrradiationYi Yin, Rui Li, Kangling Xu, et al.
Pageof 43